ClinConnect ClinConnect Logo
Search / Trial NCT07079046

Efficacy of Satisens® in Reducing Emotional Eating

Launched by JOSÉ ENRIQUE DE LA RUBIA ORTÍ, PH · Jul 18, 2025

Trial Information

Current as of July 26, 2025

Not yet recruiting

Keywords

Emotional Eating Appetite Regulation Food Craving Sweet Cravings Obesity Prevention Dietary Supplement Plant Extracts Lemon Verbena Hibiscus Sabdariffa Polyphenols Inflammation Nutritional Intervention Clinical Trial Biomarkers

ClinConnect Summary

This clinical trial is looking at whether a natural dietary supplement called Satisens® can help reduce emotional eating and cravings for sweets in healthy adults. Emotional eating is when people eat in response to feelings rather than hunger, which can sometimes lead to weight gain. The study will also look at how Satisens® might affect certain hormones, brain chemicals, and inflammation in the body to better understand how it works.

Adults between 18 and 65 years old who are generally healthy and not dealing with any long-term illnesses may be able to join the study. Pregnant or breastfeeding women, people taking certain medications or supplements, and those who exercise more than three hours a week won’t be eligible. Participants will be asked to take the supplement and have some tests done to check their body’s responses. This study hasn’t started recruiting yet, but it aims to find out if Satisens® could be a helpful tool for managing emotional eating and cravings.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults aged 18 to 65 years
  • Healthy individuals without chronic diseases
  • Able to provide informed consent
  • Exclusion Criteria:
  • Pregnant or breastfeeding women
  • Individuals taking medications or supplements that may interfere with study variables
  • Individuals engaging in more than 3 hours of active exercise per week

About José Enrique De La Rubia Ortí, Ph

José Enrique de la Rubia Ortí, PhD, is a clinical trial sponsor with expertise in biomedical research and clinical development. He is committed to advancing medical knowledge through the design and oversight of rigorous clinical studies, focusing on innovative therapies and evidence-based outcomes. Dr. de la Rubia Ortí’s work emphasizes scientific integrity and patient safety, contributing to the development of effective healthcare solutions.

Locations

Valencia, Valencian Community, Spain

Patients applied

0 patients applied

Trial Officials

José Enrique Dr. de la Rubia Ortí, PhD in Pharmacy

Principal Investigator

Universidad Católica de Valencia San Vicente Mártir

Gonzalo Mariscal Ruiz-Rico

Principal Investigator

Universidad Católica de Valencia San Vicente Mártir

Ana Belén Carriquí Suárez

Study Director

Facultad de Medicina y Ciencias de la Salud, Universidad Católica de Valencia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported